Last close ₹495.50up ₹20.35 (4.28%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹475.15.
52-week range of traded prices to 23 Oct 2026
₹153.55Low, 11 Nov 2025₹820.00High, 4 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹850 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 2 Jul 2026
- 32.9
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 2 Jul 2026
- 21.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 2 Jul 2026
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 2 Jul 2026
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day.
- 18,500
Results
Consolidated; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 2 Jul
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹65 Crdown 2.02%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹17 Crdown 40.30%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 26.2%
Revenue by year
Peak revenue ₹132 Cr, year to Mar 2026
Net profit by year, a loss in red
| ₹ crore | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025Filed 23 May | Sep 2025Filed 14 Nov | Mar 2026Filed 2 Jul |
|---|---|---|---|---|---|---|
| Revenue | 22.1 | 26.6 | 23.8 | 31.8 | 66.7 | 65.3 |
| Net profit | 4.2 | 6.1 | 5.2 | 9.9 | 28.6 | 17.1 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 19.2% | 22.8% | 21.9% | 31.2% | 42.9% | 26.2% |
Consolidated. The 6 half years from Sep 2023, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- UgandaUganda, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹115 Crup 168.11%79.0%
- IndiaIndia, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹25 Crup 256.87%17.1%
- UAEUAE, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹4 Cr3.0%
- NigeriaNigeria, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹1 Crdown 83.76%0.5%
- MauritiusMauritius, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹0 Cr0.2%
- TanzaniaTanzania, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹0 Crdown 67.06%0.1%
The pill is the change in revenue on the year before; the share is of all the businesses together.
Valuation
Today, against the company's own history. Not shown, P/B: the share count changed after the latest balance sheet (a rights issue, a buyback, an allotment or a listing), which does not yet hold the money it brought or returned. Not shown, EV/EBITDA: the share count changed after the latest balance sheet (a rights issue, a buyback, an allotment or a listing), which does not yet hold the money it brought or returned. Dividend yield is not shown: no dividend in the years on record.PE ratio and valuation history
Price to earningsPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
At or below today's level on 86% of 590 trading days since May 2024.
LowestHighest
Its median19.9Industry median41.4
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +158.9% | +69.6% | +52.6% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Peers and competitors
Hospital, 38 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Unihealth Hospitals in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 K M C Speciality Hospitals (India)KMCSHIL | 2,339 | 41.9 | 11.1 | 23.6 | +35.1% | +137.8% | 29.8% | 27.5% | 0.00% |
 Gujarat Kidney and Super SpecialityGKSL | 1,391 | – | 5.5 | 50.6 | – | – | – | 8.0% | 0.00% |
 ShalbySHALBY | 1,225 | 31.2 | 1.2 | 12.2 | +6.5% | – | 3.9% | 4.6% | 0.00% |
 GPT HealthcareGPTHEALTH | 1,075 | 22.7 | 4.0 | 11.9 | +18.1% | −0.8% | 18.3% | 22.1% | 1.91% |
 Rays of BeliefMOMSBELIEF | 552 | – | – | – | – | – | – | – | 0.00% |
 Asarfi HospitalASARFI | 335 | 20.1 | 3.4 | – | +43.2% | +57.5% | 18.7% | – | 0.00% |
 Lotus Eye Hospital and InstituteLOTUSEYE | 234 | 1,565.6 | 3.9 | 49.7 | +14.1% | −77.4% | 0.2% | 0.4% | 0.00% |
 Aashka HospitalsAASHKA | 217 | 64.9 | 2.1 | – | +1.6% | +2.2% | 3.3% | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
Sep 2026
28 Sep · Meeting
26 Sep · Analysts
22 Sep · Giving guarantees/indemnity/ becoming a surety for third party
22 Sep · Giving guarantees/indemnity/ becoming a surety for third party
22 Sep · Analysts
Unihealth Hospitals share price by year
Each calendar year to 2025.Unihealth Hospitals share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 299.10 | +103.5% | 372.00 | 131.00 |
| 2024 | 147.00 | +14.8% | 171.35 | 112.00 |
| 2023 | 128.10 | – | 142.35 | 122.05 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2023 is from its first session, 21 Sep 2023.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 484.90 | 505.00 | 480.00 | 495.50 | 488.46 | 18,500 | – |
| 22 Oct 2026 | 474.00 | 481.00 | 464.00 | 475.15 | 475.37 | 15,000 | 66.7% |
| 21 Oct 2026 | 501.00 | 516.95 | 470.00 | 479.60 | 482.08 | 28,000 | 64.3% |
| 19 Oct 2026 | 523.00 | 523.00 | 507.00 | 511.50 | 515.17 | 8,000 | 68.8% |
| 16 Oct 2026 | 570.00 | 570.00 | 537.00 | 539.95 | 550.09 | 5,000 | 70.0% |
| 15 Oct 2026 | 557.00 | 587.00 | 550.00 | 576.80 | 574.23 | 19,000 | 68.4% |
| 14 Oct 2026 | 525.00 | 553.50 | 519.40 | 549.85 | 538.63 | 14,500 | 75.9% |
| 13 Oct 2026 | 520.00 | 535.00 | 462.00 | 516.00 | 489.32 | 1,09,000 | 58.3% |
| 12 Oct 2026 | 544.05 | 546.50 | 520.00 | 520.90 | 528.83 | 20,000 | – |
| 9 Oct 2026 | 565.00 | 565.00 | 530.55 | 554.75 | 542.95 | 10,500 | 57.1% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Unihealth Hospitals Limited
- NSE symbol
- UNIHEALTH
- ISIN
- INE0PRF01011
- Industry
- Healthcare Services
- Listed
- Sep 2023
- Face value
- ₹10